⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLYS News
Mineralys Therapeutics, Inc. Common Stock
Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
globenewswire.com
MLYS
Form 8-K
sec.gov
MLYS
Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
MLYS
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MLYS
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
globenewswire.com
MLYS
Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026
globenewswire.com
MLYS
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
globenewswire.com
MLYS
Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer
globenewswire.com
MLYS
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MLYS
Form 8-K
sec.gov
MLYS